178 related articles for article (PubMed ID: 24929472)
1. Effect of ferrocene-substituted porphyrin RL-91 on Candida albicans biofilm formation.
Lippert R; Vojnovic S; Mitrovic A; Jux N; Ivanović-Burmazović I; Vasiljevic B; Stankovic N
Bioorg Med Chem Lett; 2014 Aug; 24(15):3506-11. PubMed ID: 24929472
[TBL] [Abstract][Full Text] [Related]
2. Utilising polyphenols for the clinical management of Candida albicans biofilms.
Shahzad M; Sherry L; Rajendran R; Edwards CA; Combet E; Ramage G
Int J Antimicrob Agents; 2014 Sep; 44(3):269-73. PubMed ID: 25104135
[TBL] [Abstract][Full Text] [Related]
3. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
De Brucker K; De Cremer K; Cammue BP; Thevissen K
Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
[TBL] [Abstract][Full Text] [Related]
4. Effect of alkylphospholipids on Candida albicans biofilm formation and maturation.
Vila TV; Ishida K; de Souza W; Prousis K; Calogeropoulou T; Rozental S
J Antimicrob Chemother; 2013 Jan; 68(1):113-25. PubMed ID: 22995097
[TBL] [Abstract][Full Text] [Related]
5. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
Braga PC; Culici M; Alfieri M; Dal Sasso M
Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
[TBL] [Abstract][Full Text] [Related]
6. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
8. Fungicidal photodynamic effect of a twofold positively charged porphyrin against Candida albicans planktonic cells and biofilms.
Gonzales FP; Felgenträger A; Bäumler W; Maisch T
Future Microbiol; 2013 Jun; 8(6):785-97. PubMed ID: 23701333
[TBL] [Abstract][Full Text] [Related]
9. Unexplored antifungal activity of linear battacin lipopeptides against planktonic and mature biofilms of C. albicans.
De Zoysa GH; Glossop HD; Sarojini V
Eur J Med Chem; 2018 Feb; 146():344-353. PubMed ID: 29407961
[TBL] [Abstract][Full Text] [Related]
10. The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms.
Vriens K; Cools TL; Harvey PJ; Craik DJ; Braem A; Vleugels J; De Coninck B; Cammue BP; Thevissen K
Peptides; 2016 Jan; 75():71-9. PubMed ID: 26592804
[TBL] [Abstract][Full Text] [Related]
11. Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors.
Vila T; Lopez-Ribot JL
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795383
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
13. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro.
Ramage G; Jose A; Coco B; Rajendran R; Rautemaa R; Murray C; Lappin DF; Bagg J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):456-60. PubMed ID: 21310633
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin.
Messier C; Epifano F; Genovese S; Grenier D
Phytomedicine; 2011 Mar; 18(5):380-3. PubMed ID: 21353508
[TBL] [Abstract][Full Text] [Related]
15. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
16. The Organochalcogen Compound (MeOPhSe)2 Inhibits Both Formation and the Viability of the Biofilm Produced by Candida albicans, at Different Stages of Development.
de Amorim LMM; Braga MT; Carvalho ML; de Oliveira IR; Querobino SM; Alberto-Silva C; da Rocha JBT; Costa MS
Curr Pharm Des; 2018; 24(33):3964-3971. PubMed ID: 30465492
[TBL] [Abstract][Full Text] [Related]
17. Tramadol, an Opioid Receptor Agonist: An Inhibitor of Growth, Morphogenesis, and Biofilm Formation in the Human Pathogen, Candida albicans.
Kathwate GH; Karuppayil SM
Assay Drug Dev Technol; 2016 Dec; 14(10):567-572. PubMed ID: 27982704
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vancomycin and the interaction between tigecycline and antifungals.
Ku TS; Palanisamy SK; Lee SA
Int J Antimicrob Agents; 2010 Nov; 36(5):441-6. PubMed ID: 20685088
[TBL] [Abstract][Full Text] [Related]
19. Anti-biofilm activity of the metabolites of Streptomyces chrestomyceticus strain ADP4 against Candida albicans.
Srivastava V; Dubey AK
J Biosci Bioeng; 2016 Oct; 122(4):434-40. PubMed ID: 27117484
[TBL] [Abstract][Full Text] [Related]
20. Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans.
Raut JS; Shinde RB; Chauhan NM; Karuppayil SM
Biofouling; 2013; 29(1):87-96. PubMed ID: 23216018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
